This page is your gateway to the Roche's presence at WMS 2024.
Explore it to learn more about our commitment to Neuromuscular Diseases.
Just click one of the options below to check posters, orals, presentations, symposia information and much more.
Impact of disease-modifying therapies on bulbar function in children and adults living with SMA: Learnings and limitations
You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.
You are Leaving the Global Medically Site
By following this link, you are being redirected to another Roche page.